- Guide to PHARMACOLOGY
Molecular properties generated using the CDK
|No information available.|
|Summary of Clinical Use|
|The 1981 US FDA approval for this compound is in combination with pyrimethamine (trade name Fansidar®). Sulfadoxine is listed in the World Health Organisation's 21st Essential Medicines List (2019) as a curative treatment for uncomplicated P. falciparum malaria in combination with pyrimethamine and artesunate. This is one of the artemisinin-based combination therapies (ACTs) recommended in the WHO's Guidelines for the treatment of malaria .
The link to extended ADME data provided below is for the combined formulation with pyrimethamine.
For extended ADME data see the following: